Steatohepatitis/Metabolic Liver Disease

Top Story

InSphero launches NAFLD, NASH cellular drug development platform

July 18, 2019

NASH update: Expert opinions on awareness, potential therapeutics

July 15, 2019
Many experts consider the rising rates of nonalcoholic steatohepatitis to be nearing “epidemic levels” and, as such, will require increased awareness among…
In the Journals

Liver fat biomarker decreases after exercise, improving metabolic profile

July 11, 2019
Levels of dimethylguanidino valeric acid, a metabolite that was recently determined to be a circulating biomarker of liver fat, correlated with improved lipid traits and…
In the Journals

VCTE superior marker for measuring fibrosis in patients with HBV/HIV

July 10, 2019
Vibration-controlled transient elastography outperformed aspartate aminotransferase to platelet ratio index and Fibrosis-4 index as a noninvasive biomarker for advanced…
More Headlines »
CME

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Video
Meeting News

VIDEO: Acute intermittent porphyria therapeutic progresses to phase 3

November 12, 2018
More »